749 related articles for article (PubMed ID: 24320872)
1. Modeling complex metabolic reactions, ecological systems, and financial and legal networks with MIANN models based on Markov-Wiener node descriptors.
Duardo-Sánchez A; Munteanu CR; Riera-Fernández P; López-Díaz A; Pazos A; González-Díaz H
J Chem Inf Model; 2014 Jan; 54(1):16-29. PubMed ID: 24320872
[TBL] [Abstract][Full Text] [Related]
2. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
[TBL] [Abstract][Full Text] [Related]
3. The Rücker-Markov invariants of complex Bio-Systems: applications in Parasitology and Neuroinformatics.
González-Díaz H; Riera-Fernández P; Pazos A; Munteanu CR
Biosystems; 2013 Mar; 111(3):199-207. PubMed ID: 23454544
[TBL] [Abstract][Full Text] [Related]
4. New Markov-autocorrelation indices for re-evaluation of links in chemical and biological complex networks used in metabolomics, parasitology, neurosciences, and epidemiology.
González-Díaz H; Riera-Fernández P
J Chem Inf Model; 2012 Dec; 52(12):3331-40. PubMed ID: 23121444
[TBL] [Abstract][Full Text] [Related]
5. MIANN models in medicinal, physical and organic chemistry.
González-Díaz H; Arrasate S; Sotomayor N; Lete E; Munteanu CR; Pazos A; Besada-Porto L; Ruso JM
Curr Top Med Chem; 2013; 13(5):619-41. PubMed ID: 23548024
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Proteome-Property Relationships (QPPRs). Part 1: finding biomarkers of organic drugs with mean Markov connectivity indices of spiral networks of blood mass spectra.
Cruz-Monteagudo M; Munteanu CR; Borges F; Cordeiro MN; Uriarte E; González-Díaz H
Bioorg Med Chem; 2008 Nov; 16(22):9684-93. PubMed ID: 18951807
[TBL] [Abstract][Full Text] [Related]
7. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
8. ANN multiscale model of anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks.
González-Díaz H; Herrera-Ibatá DM; Duardo-Sánchez A; Munteanu CR; Orbegozo-Medina RA; Pazos A
J Chem Inf Model; 2014 Mar; 54(3):744-55. PubMed ID: 24521170
[TBL] [Abstract][Full Text] [Related]
9. Predicting Metabolic Reaction Networks with Perturbation-Theory Machine Learning (PTML) Models.
Diéguez-Santana K; Casañola-Martin GM; Green JR; Rasulev B; González-Díaz H
Curr Top Med Chem; 2021; 21(9):819-827. PubMed ID: 33797370
[TBL] [Abstract][Full Text] [Related]
10. From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices.
Riera-Fernández P; Martín-Romalde R; Prado-Prado FJ; Escobar M; Munteanu CR; Concu R; Duardo-Sanchez A; González-Díaz H
Curr Top Med Chem; 2012; 12(8):927-60. PubMed ID: 22352918
[TBL] [Abstract][Full Text] [Related]
11. From chemical graphs in computer-aided drug design to general Markov-Galvez indices of drug-target, proteome, drug-parasitic disease, technological, and social-legal networks.
Riera-Fernández P; Munteanu CR; Dorado J; Martin-Romalde R; Duardo-Sanchez A; González-Diaz H
Curr Comput Aided Drug Des; 2011 Dec; 7(4):315-37. PubMed ID: 22050683
[TBL] [Abstract][Full Text] [Related]
12. Visual reasoning about social networks using centrality sensitivity.
Correa CD; Crnovrsanin T; Ma KL
IEEE Trans Vis Comput Graph; 2012 Jan; 18(1):106-20. PubMed ID: 22076488
[TBL] [Abstract][Full Text] [Related]
13. MISS-Prot: web server for self/non-self discrimination of protein residue networks in parasites; theory and experiments in Fasciola peptides and Anisakis allergens.
González-Díaz H; Muíño L; Anadón AM; Romaris F; Prado-Prado FJ; Munteanu CR; Dorado J; Sierra AP; Mezo M; González-Warleta M; Gárate T; Ubeira FM
Mol Biosyst; 2011 Jun; 7(6):1938-55. PubMed ID: 21468430
[TBL] [Abstract][Full Text] [Related]
14. METANNOGEN: compiling features of biochemical reactions needed for the reconstruction of metabolic networks.
Gille C; Hoffmann S; Holzhütter HG
BMC Syst Biol; 2007 Jan; 1():5. PubMed ID: 17408512
[TBL] [Abstract][Full Text] [Related]
15. Biological Network Inference and analysis using SEBINI and CABIN.
Taylor R; Singhal M
Methods Mol Biol; 2009; 541():551-76. PubMed ID: 19381531
[TBL] [Abstract][Full Text] [Related]
16. Gene expression complex networks: synthesis, identification, and analysis.
Lopes FM; Cesar RM; Costa Lda F
J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
[TBL] [Abstract][Full Text] [Related]
17. An extended bioreaction database that significantly improves reconstruction and analysis of genome-scale metabolic networks.
Stelzer M; Sun J; Kamphans T; Fekete SP; Zeng AP
Integr Biol (Camb); 2011 Nov; 3(11):1071-86. PubMed ID: 21952610
[TBL] [Abstract][Full Text] [Related]
18. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
[TBL] [Abstract][Full Text] [Related]
19. Structural comparison of metabolic networks in selected single cell organisms.
Zhu D; Qin ZS
BMC Bioinformatics; 2005 Jan; 6():8. PubMed ID: 15649332
[TBL] [Abstract][Full Text] [Related]
20. Neural networks in building QSAR models.
Baskin II; Palyulin VA; Zefirov NS
Methods Mol Biol; 2008; 458():137-58. PubMed ID: 19065809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
